587 related articles for article (PubMed ID: 28382567)
1. Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia.
Lebensburger JD; Cutter GR; Howard TH; Muntner P; Feig DI
Pediatr Nephrol; 2017 Sep; 32(9):1565-1573. PubMed ID: 28382567
[TBL] [Abstract][Full Text] [Related]
2. Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.
Rodenbach KE; Schneider MF; Furth SL; Moxey-Mims MM; Mitsnefes MM; Weaver DJ; Warady BA; Schwartz GJ
Am J Kidney Dis; 2015 Dec; 66(6):984-92. PubMed ID: 26209544
[TBL] [Abstract][Full Text] [Related]
3. Hyperuricemia and abnormal nocturnal dipping impact glomerular filtration rate in patients with sickle cell anemia.
Lebensburger JD; Aban I; Hilliard LM; Feig DI
Am J Hematol; 2021 May; 96(5):E143-E146. PubMed ID: 33524174
[No Abstract] [Full Text] [Related]
4. Hyperuricemia is associated with a lower glomerular filtration rate in pediatric sickle cell disease patients.
Kaspar CDW; Beach I; Newlin J; Sisler I; Feig D; Smith W
Pediatr Nephrol; 2020 May; 35(5):883-889. PubMed ID: 31960140
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure abnormalities in children with sickle cell anemia.
Becker AM; Goldberg JH; Henson M; Ahn C; Tong L; Baum M; Buchanan GR
Pediatr Blood Cancer; 2014 Mar; 61(3):518-22. PubMed ID: 24424792
[TBL] [Abstract][Full Text] [Related]
6. Prospective analysis of the association of ambulatory blood pressure characteristics with incident chronic kidney disease.
McMullan CJ; Hickson DA; Taylor HA; Forman JP
J Hypertens; 2015 Sep; 33(9):1939-46; discussion 1946. PubMed ID: 26066645
[TBL] [Abstract][Full Text] [Related]
7. Augmented Association Between Blood Pressure and Proteinuria in Hyperuricemic Patients With Nonnephrotic Chronic Kidney Disease.
Kohagura K; Kochi M; Miyagi T; Zamami R; Nagahama K; Yonemoto K; Ohya Y
Am J Hypertens; 2018 Mar; 31(4):480-485. PubMed ID: 28927237
[TBL] [Abstract][Full Text] [Related]
8. Effects of topiroxostat in hyperuricemic patients with chronic kidney disease.
Horino T; Hatakeyama Y; Ichii O; Matsumoto T; Shimamura Y; Inoue K; Terada Y; Okuhara Y
Clin Exp Nephrol; 2018 Apr; 22(2):337-345. PubMed ID: 28752287
[TBL] [Abstract][Full Text] [Related]
9. Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project.
Russo E; Viazzi F; Pontremoli R; Barbagallo CM; Bombelli M; Casiglia E; Cicero AFG; Cirillo M; Cirillo P; Desideri G; D'Elia L; Ferri C; Galletti F; Gesualdo L; Giannattasio C; Iaccarino G; Leoncini G; Mallamaci F; Maloberti A; Masi S; Mengozzi A; Mazza A; Muiesan ML; Nazzaro P; Palatini P; Parati G; Rattazzi M; Rivasi G; Salvetti M; Tikhonoff V; Tocci G; Ungar A; Verdecchia P; Virdis A; Volpe M; Grassi G; Borghi C;
J Nephrol; 2022 Jan; 35(1):211-221. PubMed ID: 33755930
[TBL] [Abstract][Full Text] [Related]
10. Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.
Neri L; Rocca Rey LA; Lentine KL; Hinyard LJ; Pinsky B; Xiao H; Dukes J; Schnitzler MA
Am J Kidney Dis; 2011 Sep; 58(3):398-408. PubMed ID: 21783292
[TBL] [Abstract][Full Text] [Related]
11. Gender-specific association between uric acid level and chronic kidney disease in the elderly health checkup population in China.
Yang Y; Zhou W; Wang Y; Zhou R
Ren Fail; 2019 Nov; 41(1):197-203. PubMed ID: 30973288
[TBL] [Abstract][Full Text] [Related]
12. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
[TBL] [Abstract][Full Text] [Related]
13. Impact of Uric Acid on Hypertension Occurrence and Target Organ Damage: Insights From the STANISLAS Cohort With a 20-Year Follow-up.
Kanbay M; Girerd N; Machu JL; Bozec E; Duarte K; Boivin JM; Wagner S; Ferreira JP; Zannad F; Rossignol P
Am J Hypertens; 2020 Sep; 33(9):869-878. PubMed ID: 32267470
[TBL] [Abstract][Full Text] [Related]
14. Determinants of hyperuricemia in non-dialysed chronic kidney disease patients in three hospitals in Cameroon.
Doualla M; Halle MP; Moutchia J; Tegang S; Ashuntantang G
BMC Nephrol; 2018 Jul; 19(1):169. PubMed ID: 29986666
[TBL] [Abstract][Full Text] [Related]
15. Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney mass.
Galán I; Goicoechea M; Quiroga B; Macías N; Santos A; García de Vinuesa MS; Verdalles Ú; Cedeño S; Verde E; Pérez de José A; García A; Luño J
Nefrologia (Engl Ed); 2018; 38(1):73-78. PubMed ID: 28869042
[TBL] [Abstract][Full Text] [Related]
16. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.
Zoppini G; Targher G; Chonchol M; Ortalda V; Abaterusso C; Pichiri I; Negri C; Bonora E
Diabetes Care; 2012 Jan; 35(1):99-104. PubMed ID: 22028277
[TBL] [Abstract][Full Text] [Related]
17. Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population.
Chang HY; Tung CW; Lee PH; Lei CC; Hsu YC; Chang HH; Yang HF; Lu LC; Jong MC; Chen CY; Fang KY; Chao YS; Shih YH; Lin CL
Am J Med Sci; 2010 Jun; 339(6):509-15. PubMed ID: 20421785
[TBL] [Abstract][Full Text] [Related]
18. Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease.
Ghane Sharbaf F; Assadi F
Pediatr Nephrol; 2018 Aug; 33(8):1405-1409. PubMed ID: 29549464
[TBL] [Abstract][Full Text] [Related]
19. Serum uric acid level as an indicator for CKD regression and progression in patients with type 2 diabetes mellitus-a 4.6-year cohort study.
Chang YH; Lei CC; Lin KC; Chang DM; Hsieh CH; Lee YJ
Diabetes Metab Res Rev; 2016 Sep; 32(6):557-64. PubMed ID: 26590369
[TBL] [Abstract][Full Text] [Related]
20. The assessment of renal function in patients with newly diagnosed hypertension - the role of hyperuricemia as a risk factor for chronic kidney disease - preliminary study.
Komendarek-Kowalska M
Pol Merkur Lekarski; 2017 May; 42(251):193-196. PubMed ID: 28557965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
